BC Week In Review | Mar 15, 2004
Company News

Paradigm, TissueInformatics deal

PDGM completed its previously announced acquisition of pathology software company TissueInformatics (see BioCentury, Feb. 2). PDGM issued 3.4 million shares valued at $4.5 million based on PDGM's March 11 close at $1.33. TissueInformatics is eligible...
BC Week In Review | Feb 2, 2004
Company News

Paradigm, TissueInformatics deal

PDGM will acquire pathology software company TissueInformatics for 3.4 million shares up front, plus 2.7 million shares based on performance milestones. The deal would be worth up to $7.8 million based on PDGM's close of...
BC Week In Review | Dec 8, 2003
Company News

TissueInformatics board of directors update

TissueInformatics Inc. , Pittsburgh, Penn.   Business: Functional genomics   Appointed: Douglas Morton, retired VP of worldwide discovery/strategic alliances at Pfizer Inc.  ...
BioCentury | Nov 24, 2003
Finance

Ebb & Flow

NASDAQ's revamped biotechnology index takes effect today, although many purists may find that "biotech" has been diluted in the new NBI. In the past, NASDAQ used the SEC's Standard Industrial Classification (SIC) system, which was...
BC Week In Review | Mar 24, 2003
Company News

Paradigm, TissueInformatics deal

The companies will identify biomarkers that signal the presence and progression of chronic liver disease. PDGM will perform metabolomics studies on tissue, urine and plasma to identify disease-specific biochemical profiles, and TissueInformatics will perform automated,...
BC Extra | Mar 19, 2003
Company News

Paradigm Genetics, TissueInformatics biomarker deal

PDGM and TissueInformatics (Pittsburgh, Penn.) will research biomarkers that signal the presence and progression of chronic liver disease. PDGM will perform metabolomics studies on tissue, urine and plasma to identify disease-specific biochemical profiles, and TissueInformatics...
BC Week In Review | Jan 27, 2003
Company News

TissueInformatics, Windber Research Institute deal

TissueInformatics and the institute partnered to develop a software package for the quantitative structural analysis of breast cancer tissue. The software will be offered as a module for TissueInformatics' TissueAnalytics tissue analysis software. TissueInformatics Inc....
BioCentury | Aug 26, 2002
Finance

Ebb & Flow

The upswing in U.S. biotech stocks is leading to hopes in Europe that the long down trend has been stopped, at least through year end if not for the long term. Last week, the BioCentury...
BC Week In Review | Jul 29, 2002
Company News

TissueInformatics management update

TissueInformatics Inc. , Pittsburgh, Penn.   Business: Bioinformatics   Hired: Todd Joron as SVP of sales and marketing, formerly president and CEO of Bibliomondo Inc.  ...
BC Week In Review | Apr 29, 2002
Company News

DiAthegen LLC, TissueInformatics deal

The companies formed a five-year joint venture to discover new therapeutic and diagnostic targets related to Type II diabetes. The partners will use DiAthegen's animal modeling, molecular biology and transgenic animal capabilities and TissueInformatics' automated...
Items per page:
1 - 10 of 22
BC Week In Review | Mar 15, 2004
Company News

Paradigm, TissueInformatics deal

PDGM completed its previously announced acquisition of pathology software company TissueInformatics (see BioCentury, Feb. 2). PDGM issued 3.4 million shares valued at $4.5 million based on PDGM's March 11 close at $1.33. TissueInformatics is eligible...
BC Week In Review | Feb 2, 2004
Company News

Paradigm, TissueInformatics deal

PDGM will acquire pathology software company TissueInformatics for 3.4 million shares up front, plus 2.7 million shares based on performance milestones. The deal would be worth up to $7.8 million based on PDGM's close of...
BC Week In Review | Dec 8, 2003
Company News

TissueInformatics board of directors update

TissueInformatics Inc. , Pittsburgh, Penn.   Business: Functional genomics   Appointed: Douglas Morton, retired VP of worldwide discovery/strategic alliances at Pfizer Inc.  ...
BioCentury | Nov 24, 2003
Finance

Ebb & Flow

NASDAQ's revamped biotechnology index takes effect today, although many purists may find that "biotech" has been diluted in the new NBI. In the past, NASDAQ used the SEC's Standard Industrial Classification (SIC) system, which was...
BC Week In Review | Mar 24, 2003
Company News

Paradigm, TissueInformatics deal

The companies will identify biomarkers that signal the presence and progression of chronic liver disease. PDGM will perform metabolomics studies on tissue, urine and plasma to identify disease-specific biochemical profiles, and TissueInformatics will perform automated,...
BC Extra | Mar 19, 2003
Company News

Paradigm Genetics, TissueInformatics biomarker deal

PDGM and TissueInformatics (Pittsburgh, Penn.) will research biomarkers that signal the presence and progression of chronic liver disease. PDGM will perform metabolomics studies on tissue, urine and plasma to identify disease-specific biochemical profiles, and TissueInformatics...
BC Week In Review | Jan 27, 2003
Company News

TissueInformatics, Windber Research Institute deal

TissueInformatics and the institute partnered to develop a software package for the quantitative structural analysis of breast cancer tissue. The software will be offered as a module for TissueInformatics' TissueAnalytics tissue analysis software. TissueInformatics Inc....
BioCentury | Aug 26, 2002
Finance

Ebb & Flow

The upswing in U.S. biotech stocks is leading to hopes in Europe that the long down trend has been stopped, at least through year end if not for the long term. Last week, the BioCentury...
BC Week In Review | Jul 29, 2002
Company News

TissueInformatics management update

TissueInformatics Inc. , Pittsburgh, Penn.   Business: Bioinformatics   Hired: Todd Joron as SVP of sales and marketing, formerly president and CEO of Bibliomondo Inc.  ...
BC Week In Review | Apr 29, 2002
Company News

DiAthegen LLC, TissueInformatics deal

The companies formed a five-year joint venture to discover new therapeutic and diagnostic targets related to Type II diabetes. The partners will use DiAthegen's animal modeling, molecular biology and transgenic animal capabilities and TissueInformatics' automated...
Items per page:
1 - 10 of 22